Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $531.92 ($5.2M) on 2026-10-09, disclosed to the SEC on 2026-10-13.
Scheduled sale ($5.2M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $531.92 | 120 | $64K | 1.2% |
| 2 | $533.80 | 320 | $171K | 3.3% |
| 3 | $534.80 | 640 | $342K | 6.6% |
| 4 | $536.09 | 400 | $214K | 4.1% |
| 5 | $537.05 | 360 | $193K | 3.7% |
| 6 | $538.33 | 400 |
| $215K |
| 4.2% |
| 7 | $539.23 | 200 | $108K | 2.1% |
| 8 | $540.74 | 320 | $173K | 3.3% |
| 9 | $541.51 | 40 | $22K | 0.4% |
| 10 | $543.21 | 240 | $130K | 2.5% |
| 11 | $544.54 | 400 | $218K | 4.2% |
| 12 | $545.90 | 400 | $218K | 4.2% |
| 13 | $546.60 | 240 | $131K | 2.5% |
| 14 | $548.01 | 878 | $481K | 9.3% |
| 15 | $548.93 | 2,641 | $1.4M | 28.0% |
| 16 | $549.93 | 1,478 | $813K | 15.7% |
| 17 | $550.72 | 423 | $233K | 4.5% |
| Total | $544.94 avg | 9,500 | $5.2M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-14 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-09 | $5.1M | — | Filing → |